Effects of repeated 5-HT6 receptor stimulation on BDNF gene expression and cell survival

Neuroscience Letters

Volumn 553, Issue , 2013, Pages 211-215

  de Foubert, Georgina ^a   Khundakar, Ahmad A ^b   Zetterström, Tyra S ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

5 HT6 receptors; Antidepressant drugs; BDNF; Brain derived neurotrophic factor; Neurogenesis; Serotonin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LY 586713; SEROTONIN 6 RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; GENE EXPRESSION; GRANULAR CELL; HIPPOCAMPUS; MALE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION; UPREGULATION;

5-HT(6) RECEPTORS; ANTIDEPRESSANT DRUGS; BDNF; BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROGENESIS; SEROTONIN;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL PROLIFERATION; CELL SURVIVAL; MALE; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN RECEPTOR AGONISTS; TIME FACTORS;

EID: 84884362398     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.08.029     Document Type: Article

References (28)

1. Aid T., Kazantseva A., Piirsoo M., Palm K., Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 2007, 85:525-535.
2. Borsini F., Bordi F., Riccioni T. 5-HT6 pharmacology inconsistencies. Pharmacol. Biochem. Behav. 2011, 98:169-172.
3. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50:260-265.
4. Coppell A.L., Pei Q., Zetterström T.S. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 2003, 44:903-910.
5. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., Murray T.K., Gaillard J.P., Deville C., Xhenseval V., Thomas C.E., O'Neill M.J., Zetterström T.S. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 2004, 128:597-604.
6. De Foubert G., O'Neill M.J., Zetterström T.S. Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression. Neuroscience 2007, 147:778-785.
7. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997, 54:597-606.
8. Gorgulu Y., Caliyurt O. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res. Bull. 2009, 80:158-162.
9. Khundakar A.A., Zetterström T.S. Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation. Brain Res. 2006, 1106:12-20.
10. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
11. Max S.I., Monsma F.J., Sibley D.R. Agonist-induced desensitization of 5-HT6 serotonin receptor-coupled adenylyl cyclase in stably transfected HEK-293 cells. J. Seroton. Res. 1995, 2:101-116.
12. Musazzi L., Cattaneo A., Tardito D., Barbon A., Gennarelli M., Barlati S., Racagni G., Popoli M. Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants. BMC Neurosci. 2009, 10:48.
13. Nakagawa S., Kim J.E., Lee R., Malberg J.E., Chen J., Steffen C., Zhang Y.J., Nestler E.J., Duman R.S. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J. Neurosci. 2002, 22:3673-3682.
14. Neto F.L., Borges G., Torres-Sanchez S., Mico J.A., Berrocoso E. Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr. Neuropharmacol. 2011, 9:530-552.
15. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
16. Nikiforuk A., Kos T., Wesolowska A. The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology (Berl.) 2011, 217:411-418.
17. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, San Diego.
18. Pei Q., Burnet P.W., Grahame-Smith D.G., Zetterström T.S. Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain. Neuroscience 1997, 78:343-350.
19. Russo-Neustadt A.A., Alejandre H., Garcia C., Ivy A.S., Chen M.J. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 2004, 29:2189-2199.
20. Sairanen M., Lucas G., Ernfors P., Castrén M., Castrén E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 2005, 25:1089-1094.
21. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
22. 6 receptor agonist: WAY-181187 and WAY-208466. Neuropsychopharmacology 2008, 33:1323-1335.
23. Svenningsson P., Tzavara E.T., Qi H., Carruthers R., Witkin J.M., Nomikos G.G., Greengard P. Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J. Neurosci. 2007, 27:4201-4209.
24. Trajkovska V., Santini M.A., Marcussen A.B., Thomsen M.S., Hansen H.H., Mikkelsen J.D., Arneberg L., Kokaia M., Knudsen G.M., Aznar S. BDNF downregulates 5-HT(2A) receptor protein levels in hippocampal cultures. Neurochem. Int. 2009, 55:697-702.
25. Wolkowitz O.M., Wolf J., Shelly W., Rosser R., Burke H.M., Lerner G.K., Reus V.I., Nelson J.C., Epel E.S., Mellon S.H. Serum BDNF levels before treatment predict SSRI response in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1623-1630.
26. Xu H., Luo C., Richardson J.S., Li X.M. Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine. Pharmacogenom. J. 2004, 4:322-331.
27. Ying S.W., Futter M., Rosenblum K., Webber M.J., Hunt S.P., Bliss T.V., Bramham C.R. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J. Neurosci. 2002, 22:1532-1540.
28. Zetterström T.S., Pei Q., Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res. Mol. Brain Res. 1998, 57:106-110.